top of page

Thank you for your interest in the ELIMINATE Trial.

 

Unfortunately, based on your responses, you are not eligible to participate in the study.

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

Phage.png
Phage.png
Phage.png

LBP-EC01 is a clinical-stage precision investigational therapeutic designed to target E. coli infections.  It is a cocktail of bacteriophages (Phages) engineered to precisely remove E. coli bacteria, which may be resistant to multiple drugs, in patients with UTIs.  

LocusBio_Row_Blue_2x.png
bottom of page